Teva Pharmaceuticals saw shares rise during Thursday's session after announcing its growth strategy. Richard Francis, president and CEO of Teva Pharmaceuticals, joined Cheddar News to discuss its pipeline of products that the company expects to help revenue.

Share:
More In Business
Be Prepared for No Rate Cuts in 2024
With stubborn inflation sticking at about 2.8%, there’s a chance that the Fed won’t cut rates this year. That might be the smarter choice in the long run.
Load More